Naoki Yanagisawa

Summary

Affiliation: Tokyo Metropolitan Komagome Hospital
Country: Japan

Publications

  1. ncbi Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    J Infect Chemother 18:66-8. 2012
  2. ncbi Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    J Infect Chemother 16:38-41. 2010
  3. ncbi Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, 3 18 22, Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Vaccine 29:5694-8. 2011
  4. ncbi Clinical characteristics of kidney disease in Japanese HIV-infected patients
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephron Clin Pract 118:c285-91. 2011
  5. ncbi [Syphilis proctitis complicated with HIV infection: a case report]
    Ken Ichiro Kobayashi
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 86:415-8. 2012
  6. ncbi Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy
    Minoru Ando
    Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephrol Dial Transplant 26:3224-9. 2011
  7. ncbi Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients
    Minoru Ando
    Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephrol Dial Transplant 26:3923-9. 2011
  8. ncbi [WHO recommended pre-exposure prophylaxis for rabies using Japanese rabies vaccine]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 82:441-4. 2008
  9. ncbi [A case of disseminated candidiasis as an initial presentation of AIDS]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 81:459-62. 2007
  10. ncbi Pathologically confirmed malignant syphilis in an HIV-infected patient
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Japan
    Intern Med 50:2423-6. 2011

Collaborators

Detail Information

Publications18

  1. ncbi Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo, 113 8677, Japan
    J Infect Chemother 18:66-8. 2012
    ..Although a 1.0-ml dose of PCEC-K administered subcutaneously is considered the standard method, the intradermal regimen using a 0.1-ml dose of PCEC-K is immunogenic, safe, and highly recommended for situations of vaccine shortage...
  2. ncbi Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    J Infect Chemother 16:38-41. 2010
    ..An accelerated schedule would be of great advantage to Japanese travelers, who could complete the required three doses for primary immunization in 1 month...
  3. ncbi Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, 3 18 22, Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Vaccine 29:5694-8. 2011
    ..There were no serious adverse events in any of the subjects receiving the vaccine. Additional study is warranted to identify a more effective method of vaccinating HIV-infected Japanese subjects...
  4. ncbi Clinical characteristics of kidney disease in Japanese HIV-infected patients
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephron Clin Pract 118:c285-91. 2011
    ..Japan is a country with an increasing number of newly infected HIV patients. However, only a few studies have investigated kidney disease in Asian populations infected with HIV...
  5. ncbi [Syphilis proctitis complicated with HIV infection: a case report]
    Ken Ichiro Kobayashi
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 86:415-8. 2012
    ..A rapid plasma reagin titer test performed 3 months after treatment demonstrated significant decrease, indicating successful treatment...
  6. ncbi Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy
    Minoru Ando
    Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephrol Dial Transplant 26:3224-9. 2011
    ..Use of urine as a diagnostic medium may allow the noninvasive detection of incipient nephropathy in these patients...
  7. ncbi Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients
    Minoru Ando
    Department of Nephrology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Nephrol Dial Transplant 26:3923-9. 2011
    ..However, there are insufficient data on how to identify subjects who are at risk for developing overt kidney disease in a human immunodeficiency virus (HIV) population...
  8. ncbi [WHO recommended pre-exposure prophylaxis for rabies using Japanese rabies vaccine]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 82:441-4. 2008
    ..Local adverse effects such as erythema and pain were noted, but none were serious. In conclusion, WHO recommended pre-exposure prophylaxis for rabies using PCEC-K is considered effective and safe...
  9. ncbi [A case of disseminated candidiasis as an initial presentation of AIDS]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 81:459-62. 2007
    ..To the best of our knowledge, this is the first report in Japan of a HIV patient to have disseminated candidiasis...
  10. ncbi Pathologically confirmed malignant syphilis in an HIV-infected patient
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Japan
    Intern Med 50:2423-6. 2011
    ..A rapid plasma reagin titer test performed 3 months after treatment revealed a 4-fold reduction in the titer, indicating successful treatment...
  11. ncbi [Prevalence of kidney disease in HIV-infected patients in Japan--A single center study]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 84:28-32. 2010
    ..However, epidemiologic and clinical variables regarding kidney disease have not been determined among HIV-infected patients in Japan...
  12. ncbi Bilateral emphysematous pyelonephritis with a splenic abscess
    Hiroshi Morioka
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Japan
    Intern Med 52:147-50. 2013
    ..Treatment with systemic antibiotics combined with the insertion of percutaneous and renoureteral catheters was successful. The patient was discharged and completed treatment without developing any subsequent complications...
  13. ncbi Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection
    Yusuke Okuma
    Department of Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo, Tokyo, 113 8677, Japan
    Int J Clin Oncol 17:462-9. 2012
    ..Japan has an increasing number of newly infected HIV patients, but clinical characteristics of lung cancer have not been well investigated in Asian populations with HIV...
  14. ncbi [Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report]
    Hirofumi Kato
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 86:287-90. 2012
    ..Symptoms did not recur after completing 8 courses of chemotherapy. PTX should be considered as an alternative agent in treating KS when there are problems with the use of PLD...
  15. ncbi A simple model for predicting incidence of chronic kidney disease in HIV-infected patients
    Minoru Ando
    Department of Nephrology, Tokyo Metropolitan Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 0021, Japan
    Clin Exp Nephrol 15:242-7. 2011
    ..Human immunodeficiency virus (HIV)-infected individuals have concurrent risk factors for chronic kidney disease (CKD), but there are no prediction models to quantify the effect of multiple factors on the development of incident CKD...
  16. ncbi [Voriconazole as an effective therapy against pulmonary aspergillosis in a man with immunodeficiency virus-infection: a case report]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 81:200-5. 2007
    ..Use of Voriconazole, a relatively new antifungal agent, may lower mortality with fewer adverse effects than conventional antifungal therapy...
  17. ncbi [Effect on anti-pertussis antibodies of reducing the amount of Japanese Diphteria-Pertussis-Tetanus vaccine among adults]
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital
    Kansenshogaku Zasshi 83:7-11. 2009
    ..The incidence of local adverse effects was higher in adults than in children, but none were serious. A Japanese DPT vaccine dose of 0.2 mL thus proved effective against pertussis in adults...
  18. ncbi HIV-positive man with ulceronecrotic skin lesions
    Naoki Yanagisawa
    Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Clin Infect Dis 47:1068-9, 1109. 2008